Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Science Translational Medicine|March 20, 2015
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanomaSiwen Hu-Lieskovan, Stephen Mok, Blanca Homet Moreno, et al.
Frontiers in Immunology|December 16, 2021
Conditional Deletion of Pdcd1 Identifies the Cell-Intrinsic Action of PD-1 on Functional CD8 T Cell Subsets for Antitumor EfficacySukanya Raghavan, Nataliya Tovbis-Shifrin, Christina Kochel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2015
Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine MedulloblastomaChristina D Pham, Catherine Flores, Changlin Yang, et al.
Neuron|November 9, 2007
Ena/VASP Is Required for neuritogenesis in the developing cortexAdam V Kwiatkowski, Douglas A Rubinson, Erik W Dent, et al.
Cancer Research|June 15, 2017
Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory CellsSelvakumar Sukumar, Douglas C Wilson, Ying Yu, et al.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2024
Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learnedLaura A Stransky, Wenhua Gao, Laura S Schmidt, et al.
Cancer Discovery|April 26, 2013
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsErick J Morris, Sharda Jha, Clifford R Restaino, et al.
Pageof 2